missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human HGF (NS0-expressed) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 294-HGN-250
1292.41 EUR valid until 2024-12-16
Use promo code "21630" to get your promotional price.
This item is not returnable.
View return policy
Description
The Recombinant Human HGF (NS0-expressed) Protein is derived from NS0. The Recombinant Human HGF (NS0-expressed) Protein has been validated for the following applications: Bioactivity.Specifications
| P14210.2 | |
| Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. | |
| alpha chain: 53.7 kDa beta chain: 26 kDa | |
| Mouse myeloma cell line, NS0-derived human HGF protein Gln32-Ser728 (Asp384Asn, Asp416Asn, Leu622Ser, His645Arg, Val678Ile) | |
| RUO | |
| deafness, autosomal recessive 39, DFNB39, EC 3.4.21, EC 3.4.21.7, fibroblast-derived tumor cytotoxic factor, F-TCF, hepatocyte growth factor (hepapoietin A; scatter factor), Hepatopoeitin-A, Hepatopoietin A, HGFB, HPTA, HPTAhepatocyte growth factor, lung fibroblast-derived mitogen, Scatter factor, SF, SFhepatopoeitin-A | |
| Unconjugated | |
| Human | |
| >95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| Bioactivity | |
| 3082 | |
| 250 μg | |
| Manual defrost freezer; Avoid repeated freeze-thaw cycles; 12 mo. from receipt, -20 to -70°C as supplied; 1 mo., 2 to 8°C under sterile conditions after reconstitution; 3 mo., -20 to -70°C under sterile conditions after reconstitution | |
| <0.10 EU per 1 μg of the protein by the LAL method. | |
| HGF | |
| HGF | |
| Reconstitute at 50 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |